Show simple item record

dc.contributor.authorCook, G
dc.contributor.authorJohn Ashcroft, A
dc.contributor.authorPratt, G
dc.contributor.authorPopat, R
dc.contributor.authorRamasamy, K
dc.contributor.authorKaiser, M
dc.contributor.authorJenner, M
dc.contributor.authorHenshaw, S
dc.contributor.authorHall, R
dc.contributor.authorSive, J
dc.contributor.authorStern, S
dc.contributor.authorStreetly, M
dc.contributor.authorBygrave, C
dc.contributor.authorSoutar, R
dc.contributor.authorRabin, N
dc.contributor.authorJackson, GH
dc.contributor.authorUnited Kingdom Myeloma Forum
dc.date.accessioned2020-07-06T13:48:38Z
dc.date.issued2020-07
dc.identifier.citationBritish journal of haematology, 2020, 190 (2), pp. e83 - e86
dc.identifier.issn0007-1048
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3812
dc.identifier.eissn1365-2141
dc.identifier.doi10.1111/bjh.16874
dc.formatPrint-Electronic
dc.format.extente83 - e86
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectUnited Kingdom Myeloma Forum
dc.subjectHumans
dc.subjectPneumonia, Viral
dc.subjectCoronavirus Infections
dc.subjectMultiple Myeloma
dc.subjectRecurrence
dc.subjectAntineoplastic Agents
dc.subjectAdult
dc.subjectAged
dc.subjectMiddle Aged
dc.subjectFemale
dc.subjectMale
dc.subjectClinical Audit
dc.subjectPandemics
dc.subjectUnited Kingdom
dc.subjectBetacoronavirus
dc.subjectCOVID-19
dc.subjectSARS-CoV-2
dc.titleReal-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.
dc.typeOther
rioxxterms.versionofrecord10.1111/bjh.16874
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2020-07
rioxxterms.typeOther
dc.relation.isPartOfBritish journal of haematology
pubs.issue2
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group
pubs.publication-statusPublished
pubs.volume190
pubs.embargo.termsNot known
icr.researchteamMyeloma Group
dc.contributor.icrauthorKaiser, Martin


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0